Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Leisch · SciRah

Researcher profile · Semantic Scholar

M. Leisch

Share profile

M. Leisch — researcher profile on SciRah

h-index: 10
Works: 37
Citations: 452

Most-cited papers

The double-edged sword of (re)expression of genes by hypomethylating agents: from viral mimicry to exploitation as priming agents for targeted immune checkpoint modulation
F. Wolff, M. Leisch, R. Greil, A. Risch +1 more
2017Cell Communication and Signaling81 citations Open access
Semantic Scholar
Next Generation Sequencing in AML—On the Way to Becoming a New Standard for Treatment Initiation and/or Modulation?
M. Leisch, Bettina Jansko, N. Zaborsky, R. Greil +1 more
2019Cancers69 citations Open access
Semantic Scholar
Plitidepsin: a potential new treatment for relapsed/refractory multiple myeloma.
M. Leisch, A. Egle, R. Greil
2019Future Oncology53 citations
Semantic Scholar
Combination Strategies for Immune-Checkpoint Blockade and Response Prediction by Artificial Intelligence
F. Huemer, M. Leisch, R. Geisberger, T. Melchardt +3 more
2020International Journal of Molecular Sciences51 citations Open access
Semantic Scholar
Outcomes of patients with chronic myelomonocytic leukaemia treated with non-curative therapies: a retrospective cohort study.
L. Pleyer, M. Leisch, A. Kourakli, E. Padron +37 more
2021The Lancet Haematology46 citations
Semantic Scholar
BIRC3 Expression Predicts CLL Progression and Defines Treatment Sensitivity via Enhanced NF-κB Nuclear Translocation
D. Asslaber, N. Wacht, M. Leisch, Yuan Qi +8 more
2018Clinical Cancer Research38 citations
Semantic Scholar
Myeloid NGS Analyses of Paired Samples from Bone Marrow and Peripheral Blood Yield Concordant Results: A Prospective Cohort Analysis of the AGMT Study Group
Bettina Jansko-Gadermeir, M. Leisch, F. Gassner, N. Zaborsky +9 more
2023Cancers19 citations Open access
Semantic Scholar
miRNA-Based Therapeutics in the Era of Immune-Checkpoint Inhibitors
F. Huemer, M. Leisch, R. Geisberger, N. Zaborsky +1 more
2021Pharmaceuticals19 citations Open access
Semantic Scholar
Evaluation of circulating cell-free DNA as a molecular monitoring tool in patients with metastatic cancer.
C. Hufnagl, M. Leisch, L. Weiss, T. Melchardt +8 more
2019Oncology Letters16 citations Open access
Semantic Scholar
Health-Related Quality of Life as Assessed by the EQ-5D-5L Predicts Outcomes of Patients Treated with Azacitidine—A Prospective Cohort Study by the AGMT
L. Pleyer, S. Heibl, C. Tinchon, S. Vallet +17 more
2023Cancers14 citations Open access
Semantic Scholar
Differences in Stem Cell Processing Lead to Distinct Secretomes Secretion-Implications for Differential Results of Previous Clinical Trials of Stem Cell Therapy for Myocardial Infarction.
B. Wernly, I. Gonçalves, A. Kiss, V. Paar +11 more
2017Biotechnology Journal9 citations
Semantic Scholar
Adverse Events in 1406 Patients Receiving 13,780 Cycles of Azacitidine within the Austrian Registry of Hypomethylating Agents—A Prospective Cohort Study of the AGMT Study-Group
M. Leisch, M. Pfeilstöcker, R. Stauder, S. Heibl +19 more
2022Cancers8 citations Open access
Semantic Scholar
IDO in MDS/AML disease progression and its role in resistance to azacitidine: a potential new drug target?
M. Leisch, R. Greil, L. Pleyer
2020British Journal of Haematology7 citations Open access
Semantic Scholar
The double-edged sword of (re)expression of genes by hypomethylating agents: from viral mimicry to exploitation as priming agents for targeted immune checkpoint modulation
F. Wolff, M. Leisch, R. Greil, A. Risch +1 more
2017Cell Communication and Signaling5 citations Open access
Semantic Scholar
Effects of the Therapeutic Armamentarium on Survival and Time to Next Treatment in CMML Subtypes: An International Analysis of 950 Cases Coordinated By the AGMT Study Group
L. Pleyer, M. Leisch, A. Kourakli, E. Padron +35 more
2019Blood4 citations Open access
Semantic Scholar
Peripheral Blood Complete Remission Provides Added Value to the Classical Definition of Morphologic Complete Remission - a Prospective Cohort Study of 1441 Patients with MDS, CMML and AML Treated within the Austrian Azacitidine Registry
L. Pleyer, Michael Pfeilstocker, R. Stauder, S. Heibl +23 more
2021Blood3 citations
Semantic Scholar
Expanding on Current Definitions of Hematologic Improvement in MDS, CMML and AML: Landmark Analyses of 1301 Patients Treated with Azacitidine in the Austrian Registry of Hypomethylating Agents By the AGMT-Study Group
L. Pleyer, Michael Pfeilstocker, R. Stauder, S. Heibl +20 more
2019Blood3 citations Open access
Semantic Scholar
Analysis of Ambient Influences Affecting Interleukin-6 Secretion in the Context of Clinical Trials of Stem Cell Therapy for Myocardial Infarction.
C. Edlinger, B. Wernly, M. Leisch, J. Kammler +5 more
2016Clinical Laboratory2 citations
Semantic Scholar
Zur Wirksamkeit der verkehrspsychologischen Rehabilitationsprogramme CONTROL und REAL fuer alkoholauffaellige Fahrer / The effectiveness of traffic-psychological rehabilitation programs CONTROL and REAL for persons driving under the influence (DUI)
T. Schuelken, M. Leisch, R. Sachse, U. Veltgens
20062 citations
Semantic Scholar
Austrian Real-world Experience With Standard of Care Brexucabtagene Autoleucel in Patients With Relapsed or Refractory Mantle-Cell Lymphoma.
Stefan Koeck, N. Rotter, O. Stiefel, M. Leisch +16 more
2026Transplantation and Cellular Therapy1 citations
Semantic Scholar
Historic Real-World Outcomes and Future Benchmarks for Patients with Diffuse Large B-Cell Lymphoma Receiving First- and Second-Line Therapy in Austria – a Large Single-Center Experience
M. Leisch, Dominik Kiem, Christoph Grabmer, A. Kugler +6 more
2026Technology in Cancer Research and Treatment1 citations Open access
Semantic Scholar
Momelotinib Is Effective in Treatment for VEXAS Syndrome: Two Cases Within the AGMT Austrian Myeloid Registry
Dominik Kiem, M. Leisch, Ildiko Toth, Marie-Christina Mayer +4 more
2025European Journal of Haematology1 citations Open access
Semantic Scholar
Stringent Nationwide Selection Criteria for CAR-T Cell Therapy Ensure Favourable Outcome of Patients with LBCL - First Data from the Austrian CAR-T Network
J. Rudzki, U. Jaeger, D. Wolf, A. Petzer +14 more
2022Blood1 citations Open access
Semantic Scholar
Two Cases of Pancytopenia with Coombs-Negative Hemolytic Anemia after Chimeric Antigen Receptor T-Cell Therapy
Dominik Kiem, M. Leisch, D. Neureiter, Theresa Haslauer +4 more
2021International Journal of Molecular Sciences1 citations Open access
Semantic Scholar
Impact of Disease Biology and Bridging Strategy on Outcomes After CAR-T Cell Therapy in Relapsed/Refractory Multiple Myeloma.
I. Strassl, A. Nikoloudis, Lina Zoe Ruesing, T. Melchardt +20 more
2026Transplantation and Cellular Therapy0 citations
Semantic Scholar
Glofitamab in Heavily Pretreated Mantle Cell Lymphoma Patients: A Multicenter Real‐World Case Series
N. Rotter, M. Raderer, A. List, F. Haslbauer +13 more
2026eJHaem0 citations Open access
Semantic Scholar
Real-world outcomes of ide-cel and cilta-cel in relapsed/refractory multiple myeloma: A nationwide, retrospective analysis in Austria.
I. Strassl, A. Nikoloudis, L. Z. Ruesing, T. Melchardt +20 more
2026British Journal of Haematology0 citations Open access
Semantic Scholar
OUTCOME OF SECOND‐LINE AXICABTAGENE CILOLEUCEL IN RELAPSED/REFRACTORY LARGE B‐CELL LYMPHOMA PATIENTS: REAL‐WORLD ANALYSIS IN THE DACH AREA (GERMANY, AUSTRIA, SWITZERLAND)
S. Call, H. Boyadzhiev, M. Leisch, E. Aydilek +11 more
2025Hematological Oncology0 citations
Semantic Scholar
Randomized comparison between isatuximab-rd versus rd induction, followed by isa-R versus R maintenance in very elderly patients with NDMM: Efficacy data on MRD after induction (AGMT-MM04 Trial)
Heinz Ludwig, T. Melchardt, E. Terpos, Jelena Bila +19 more
2025Blood0 citations
Semantic Scholar
Comparative analysis of ide-cel and cilta-cel in patients with Relapsed/Refractory multiple myeloma: A nationwide, retrospective, real-world analysis across Austria
I. Strassl, A. Nikoloudis, Lina Zoe Ruesing, T. Melchardt +18 more
2025Blood0 citations
Semantic Scholar
Real-World Comparison of Outcomes of Patients Treated with HMA Monotherapy Versus HMA-Ven - Insights from 1634 Patients Included within the Austrian Myeloid Registry of the AGMT Study Group
L. Pleyer, Patrick Klammer, Manuel Drost, H. Angermann +21 more
2024Blood0 citations
Semantic Scholar
Validation of Recent Response Criteria (ELN-22, IWG-23 and PB-CR) in 1634 MDS/CMML/AML Patients Treated with HMA or HMA-Ven Using CPH Models and a CPH Deep Neural Network - Can or Should Response Criteria be Harmonized for Similarly Treated Patients?
L. Pleyer, Marc Vaisband, Patrick Klammer, Manuel Drost +27 more
2024Blood0 citations
Semantic Scholar
S174: MYELOID NGS ANALYSES OF PAIRED SAMPLES FROM BONE MARROW AND PERIPHERAL BLOOD YIELD CONCORDANT RESULTS: A PROSPECTIVE COHORT ANALYSIS OF THE AGMT STUDY GROUP
L. Pleyer, Bettina Jansko-Gadermeir, F. Gassner, M. Leisch +9 more
2023HemaSphere0 citations Open access
Semantic Scholar
The EQ-5D-5L Predicts Treatment Outcomes and Provides Added Value to the R-IPSS in Patients with MDS, CMML or AML Treated within the Austrian Azacitidine Registry - a Prospective Cohort Study By the AGMT Study Group
L. Pleyer, S. Heibl, C. Tinchon, S. Vallet +12 more
2021Blood0 citations Open access
Semantic Scholar
S840 IMPACT OF 1ST LINE TREATMENT ON OVERALL SURVIVAL IN 1.633 PATIENTS WITH CHRONIC MYELOMONOCYTIC LEUKEMIA – A MULTINATIONAL COLLABORATIVE EFFORT COORDINATED BY THE AGMT STUDY GROUP
L. Pleyer, M. Leisch, A. Kouraklis, E. Padron +35 more
2019HemaSphere0 citations Open access
Semantic Scholar
Zur Wirksamkeit des verkehrspsychologischen Kurses "K 70" zur Wiederherstellung der Kraftfahreignung fuer alkoholauffaellige Kraftfahrer / The effectiveness and success of the traffic-psychological course program K 70 for persons driving under the influence (DUI)
T. Schuelken, M. Leisch, R. Sachse, U. Veltgens
20110 citations
Semantic Scholar
Alcohol recidivist confiscation (of Driving licence)-- Retraining of Drivers' Rehabilitation Expert-Opinion Impact Study
T. Schulken, M. Leisch, R. Sachse, U. Veltgens
20060 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

R. Greil×21
Invite
R. Greil — researcher profile on SciRah
T. Melchardt×21
Invite
T. Melchardt — researcher profile on SciRah
L. Pleyer×17
Invite
L. Pleyer — researcher profile on SciRah
A. Egle×17
Invite
A. Egle — researcher profile on SciRah

×9

Invite

S. Heibl — researcher profile on SciRah

Invite

N. Zaborsky — researcher profile on SciRah

Manuel Drost×8

Invite

Manuel Drost — researcher profile on SciRah

J. Larcher-Senn×6

Invite

J. Larcher-Senn — researcher profile on SciRah

M. Girschikofsky×6

Invite

M. Girschikofsky — researcher profile on SciRah

S. Machherndl-Spandl×6

Invite

S. Machherndl-Spandl — researcher profile on SciRah

Invite

K. Geissler — researcher profile on SciRah

Invite

C. Tinchon — researcher profile on SciRah